Skip to content
  |  Print Print this page  |  Text Size Reduce font size  Increase font size

Email Discussions

Email discussion disclaimer

Please note that all information and policies are only current at the time the response is sent and individual hospitals should be contacted to ascertain current policies and practices. The responses received are only representative of the hospitals participating in the discussion at the time and do not necessarily indicate a complete picture of current practices.

Information sharing occurs on the understanding that due acknowledgement will be given to the original source and that the information will not be quoted or used out of the context of the discussion. Permission should be sought from the original source before any policy, protocol or guideline is used or applied in another setting.



  • Safe handling of idarucizumab
    PDF ~ 166 KB
    • Intrathecal fentanyl
      PDF ~ 286 KB
      • Documentation of nitrous oxide administration
        PDF ~ 272 KB
      • March

        • Perioperative management plan for patients taking regular anticoagulant or antiplatelet agents
          PDF ~ 201 KB


        • Off-label use of rituximab in membranous nephropathy
          PDF ~ 283 KB

    Archived discussions:

    Please contact the office if you require older discussions.